Halifax, NS – Clinical trials are an important tool in finding new treatments and cures for patients. Nova Scotia Health officials reported that the Atlantic Clinical Trials Network (ACTN) was awarded up to $2.5 million from the Canadian Institutes of Health Research via its participation to CTTP (Clinical Trials Training Programs)-CANTRAIN.Read more
Clinical trials allow researchers to assess the safety and effectiveness of new drugs, treatments, and therapies for our population. It is through these studies and their collaborative networks, that medical innovation in Canada continues to evolve.Read more
Clinical trials are an essential part of the healthcare sector and a crucial component of medical research and innovation. Clinical trials allow researchers to assess if new drugs, treatments, and therapies are safe and effective for the population.Read more
RI-MUHC researchers will lead or co-lead multiple projects awarded a total of $55 million from the Canadian Institutes of Health ResearchRead more
Halifax, NS – The Atlantic Clinical Trials Network (ACTN) will receive approximately $2.5 million for the creation of various student training opportunities at the masters, PhD, postdoctoral and postdoctoral fellow levels, along with the creation of six new positions in Atlantic Canada focused on the development and coordination of clinical trial professional training within the … Read more